GLP-1s: The Second Serving Revisiting our GLP-1 Basket In case you missed it, our new portal allowing real-time tracking and performance on every thematic basket we cover and our model portfolio recently went live at citrindex.com Introduction Two years ago, CitriniResearchs third-ever thematic primer Upgrading from Overweight made a host of bold claims about the new class of weight loss drugs, GLP-1s
Spermine and spermidine can modulate LPS-induced NF-B activation, and oral administration of polyamines alleviates airway inflammation (114)
17.8% reduction in collagen fragmentation in 4 weeks (NIH)
Danish company Novo Nordisk, the maker of Ozempic and Wegovy, had already announced headline results from the study in August last year, saying that semaglutide 2.4 mg reduced the risk of major adverse cardiovascular events by 20% in overweight or obese adults in the trial
It is very important that pharmacists effectively counsel patients on titration schedules and recognize and support the treatment expectations and goals of the patient